Generics
Phase III Lonsurf Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer, According to Servier and Taiho Oncology
Login
Username:

Password: